Clinical Microbiology Market Will Be Worth $16.1 Billion By 2024 : Grand View Research, Inc.
The global clinical microbiology market was valued at USD 8.4
billion in 2015 and is expected to reach a value of USD 16.1 billion by 2024.
Key factors driving the market growth include constant introduction of advanced
products coupled with increasing demand in pharmaceutical, and clinical applications
for investigation and diagnosis of various infectious diseases.
The market is rapidly growing due to the increasing adoption
of automated and advanced technologies for laboratory instruments and analyzers
in developed countries. Growing geriatric population and thereby rising
prevalence of infectious diseases is one of the major factors boosting the
adoption of clinical microbiology in healthcare sector for disease diagnosis
and monitoring. In addition, industry is gaining high momentum with launch of innovative
products such as MALDI Biotyper, GeneXpert and Myla IT performance management
solutions. Moreover, with the U.S. FDA approving the Xpert Carba-R,
commercialization of clinical microbiology devices is expected to increase
significantly over the next few years.
In North America, the government authorities and private
companies have significantly contributed toward technology development,
research funding, and commercialization of clinical microbiology associated
devices.
Browse full research report on Clinical Microbiology
Market: http://www.grandviewresearch.com/industry-analysis/clinical-microbiology-market
Further Key Findings from the Study Suggest:
- Rapid
adoption of technology and automation of laboratory work flow, laboratory
instrument segement is expected to be the fastest growing segment with
CAGR of 8.6% over the forecast period.
- Reagents
is the largest segment with market share of 34.7% in 2015. Repeat purchase
of reagents contribute to its growth thus it is the largest growing
segment in market.
- In
2015, North America dominated the global market with largest revenue share
of 41.0%. The continuous research on infectious disease treatment, and
subsequent grant from government healthcare agencies are contributing to
the development of a strong ecosystem for the expansion of clinical
microbiology in the region.
- Asia
Pacific is expected to emerge as the fastest growing region during the
forecast period. The growing geriatric population in India, China and
Japan leading to increase in the prevalence of re-emerging infectious
diseases such as tuberculosis, cholera and typhoid in this region are
expected to promote the utilization of clinical application of
microbiology in healthcare.
- The
clinical microbiology Industry is presently dominated by a few key
participants such as bioMerieux S.A., Cepheid Inc., Danaher Corporation
and Bruker Corporation. Some of the prominent players operating in the
market include but are not limited to Becton Dickinson & Company,
Hologic Inc., Roche Diagnostics and Alere Inc. Introduction of automated
systems and innovative designs, is expected to intensify the competition
by changing the market dynamics over the forecast period.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the clinical microbiology
market by product, application, disease and region:
Product Outlook (Market revenue in USD Million, 2014 -
2024)
- Laboratory
Instruments
- Incubators
- Gram
Stainers
- Bacterial
Colony Counters
- Autoclave
Sterilizers
- Microbial
Air Samplers
- Petri
Dish Fillers
- Culture
Systems
- Microbiology
Analyzers
- Molecular
Diagnostic Instruments
- Microscopes
- Mass
Spectrometers
- Reagents
Application Outlook (Market Revenue in USD Million, 2014
- 2024)
- Respiratory
Infections
- Bloodstream
Infections
- Gastrointestinal
Infections
- Sexually
Transmitted Infections
- Urinary
tract Infections
- Periodontal
Infections
Regional Outlook (Market Revenue in USD Million,
2014 - 2024)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- Mexico
- Middle
East and Africa
- South
Africa
Access press release of this research report by Grand
View Research: http://www.grandviewresearch.com/press-release/global-clinical-microbiology-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports,
customized research reports, and consulting services. To help clients make
informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
For more information:
www.grandviewresearch.com
Comments
Post a Comment